Overview

Bone Marrow Stem Cell Infusion Following a Heart Attack

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine the safety of giving a patient's own bone marrow-derived stem cells delivered with a catheter (tube) into the coronary arteries (blood vessels of the heart). Stem cells are simple cells produced by the bone marrow that can develop into many types of cells. It is possible that these cells will decrease the size of damage caused to the heart from a heart attack and increase the pumping efficiency of the heart; which can be decreased due to a heart attack. The stem cells will be taken from bone marrow and then given back into the heart vessels.
Phase:
Phase 1
Details
Lead Sponsor:
Minneapolis Heart Institute Foundation
Collaborators:
Abbott Northwestern Hospital
Allina Health System